Key result
Severe hypertrophy in rats is linked to ~233% higher VF risk during acute ischemia.
Why the study?
The susceptibility of hypertrophied hearts to ventricular fibrillation during acute ischemia and the underlying electrophysiological mechanisms were not fully understood.
Hypertrophied rat hearts demonstrate a significantly greater susceptibility to ventricular fibrillation during acute ischemia compared to normal hearts, potentially driven by dispersion of refractoriness.
Answers are grounded in this paper and cite their sources.
Differences in rat ischemia models do not inform patient care; leaves open hypertrophy's role in human ventricular arrhythmias.
This study compared arrhythmias induced by acute ischemia in Langendorff preparations of normal and hypertrophied rat hearts. Left ventricular pressure overload was induced by partial ligation of the abdominal aorta 6 to 8 weeks prior to study. The ratio of left ventricular weight to body weight (LVW/BW) and systolic blood pressure (SBP) were significantly higher in two groups of rats with hypertrophied hearts (moderate hypertrophy: 2.68 +/- 0.06 mg/g, 182 +/- 3 mmHg; severe hypertrophy: 3.31 +/- 0.03 mg/g, 238 +/- 5 mmHg) than in normal hearts (2.18 +/- 0.03 mg/g, 125 +/- 3 mmHg), while there were no differences in body weights. During 30 min of ischemia produced by left coronary artery occlusion in the Langendorff preparations, ventricular fibrillation occurred in six of 20 (30%) normal, six of nine (67%) moderately hypertrophied, and 14 of 14 (100%) severely hypertrophied preparations (P less than 0.001 normal vs severely hypertrophied). Tachyarrhythmias occurred in 15 of 20 (75%) normal, eight of nine (89%) moderately hypertrophied, and 14 of 14 (100%) severely hypertrophied hearts. Heart rate and coronary efflux before and during the ischemic period did not differ between normal and hypertrophied hearts. The ratio of non-perfused to perfused areas of the left ventricle, measured by Evans blue dye staining and with computerized planimetry, also was not different for normal (57.6 +/- 2.3%) and hypertrophied hearts (moderate hypertrophy 62.5 +/- 3.3%, and severe hypertrophy 59.1 +/- 2.0%). Additional control studies using larger hearts from older rats also indicate that myocardial mass was not an important determinant of ischemic arrhythmias in hypertrophy. Prolongation of endocardial and epicardial conduction time during 30 min of ischemia was not different between normal and hypertrophied hearts. Action potential duration and refractory periods were significantly longer in ventricular cells of hypertrophied hearts than in normals, and superfusion with hypoxia/zero glucose solution shortened these parameters to a greater extent in hypertrophied cells. These results lead us to conclude that hypertrophied hearts have a greater susceptibility to ventricular fibrillation during acute ischemia, and that dispersion of refractoriness may play a role in this phenomenon.
No takes yet. Share an insight, caveat, or question.
Kohya et al. (1988) studied Left ventricular hypertrophy and acute ischemia (n=43). Severe left ventricular hypertrophy vs. Normal hearts was evaluated on Ventricular fibrillation during 30 min of ischemia (p=<0.001). Severely hypertrophied rat hearts had a higher incidence of ventricular fibrillation during acute ischemia compared to normal hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: